Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study

Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo

(2013) Stephen M. Stahl et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics

(2013) Joseph P. McEvoy et al.   JOURNAL OF CLINICAL PSYCHIATRY

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study

(2013) Antony Loebel et al.   SCHIZOPHRENIA RESEARCH

Lurasidone in Schizophrenia: New Information About Dosage and Place in Therapy

(2012) Leslie Citrome   ADVANCES IN THERAPY

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder

(2012) Marc De Hert et al.   CNS DRUGS

Long-term safety and tolerability of lurasidone in schizophrenia

(2012) Leslie Citrome et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

(2012) Masaaki Ogasa et al.   PSYCHOPHARMACOLOGY

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic

(2010) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients

(2010) Margaret K. Vernon et al.   SCHIZOPHRENIA RESEARCH

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

(2009) Douglas E Faries et al.   BMC Psychiatry

Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics

(2009) David C. Henderson   JOURNAL OF CLINICAL PSYCHIATRY

Lurasidone in the Treatment of Acute Schizophrenia

(2009) Mitsutaka Nakamura et al.   JOURNAL OF CLINICAL PSYCHIATRY